Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 4, 2009, Pages 201-209

  Charan Sahoo, Kanhei ^a   Arora, Sachin ^a   Goyal, Sameer ^a   Kishore, Kamal ^a   Ray, Ruma ^a   Chandra Nag, Tapas ^a   Singh Arya, Dharamvir ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

ACE inhibitors; Apoptosis; Bax; Bcl 2; Myocardial infarction; Ventricular function

Indexed keywords

BENAZEPRIL; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOVASCULAR RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PROTECTION; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REPERFUSION INJURY; UPREGULATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BENZAZEPINES; GENE EXPRESSION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR;

EID: 73349084662     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320308353059     Document Type: Article

References (50)

1. Mohanty IR, Arya DS, Gupta SK Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis. Clin Nutr 2008 ; 27: 635-642.
2. Braunwald E., Kloner RA Myocardial reperfusion: a double-edged sword? J Clin Invest 1985 ; 76: 1713-1719.
3. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998 ; 60: 619-642. (Pubitemid 28157889)
4. Buttke TM, Sandstrom PA Oxidative stress as a mediator of apoptosis. Immunol Today 1994 ; 15 (1). 7-10.
5. Gottlieb RA, Burleson KO, Kloner RA et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994 ; 94: 1621-1628.
6. Olivetti G., Abbi R., Quaini F. et al. Apoptosis in the failing human heart. N Engl J Med 1997 ; 336: 1131-1141.
7. Veinot JP, Gattinger DA, Fliss H. Early apoptosis in human myocardial infarcts. Hum Pathol 1997 ; 28: 485-492.
8. Haunstetter A., Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998 ; 82: 1111-1129.
9. Maulik N., Yoshida T., Engelman RM et al. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem 1998 ; 186: 139-145.
10. Haunstetter A., Izumo S. Future perspectives and potential implications of cardiac myocyte apoptosis. Cardiovasc Res 2000 ; 45: 795-801.
11. Galang N., Sasaki H., Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. Toxicology 2000 ; 148: 111-118.
12. Kobara M., Tatsumi T., Kambayashi D. et al. Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model. J Cardiovasc Pharmacol 2003 ; 41: 880-889.
13. Pfeffer MA, Braunwald E., Moyé LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992 ; 327: 669-677.
14. Ertl G., Kloner RA, Alexander RW et al. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 1982 ; 65 (1). 40-48.
15. Martorana PA, Kettenbach B., Breipohl G. et al. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 1990 ; 182: 395-396.
16. Ozer MK, Sahna E., Birincioglu M. et al. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats. Pharmacol Res 2002 ; 45: 257-263.
17. Liu YH, Yang XP, Sharov VG et al. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996 ; 27 (1). 7-13.
18. He H., Shi M., Yang X. et al. Comparison of cardioprotective effects using salvianolic acid B and benazepril for the treatment of chronic myocardial infarction in rats. Naunyn Schmiedebergs Arch Pharmacol 2008 ; 378: 311-322.
19. Singh VP, Le B., Khode R. et al. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 2008 ; 57: 3297-3306.
20. Mohanty I., Gupta SK, Arya DS Anti-apoptotic and cardioprotective effects of an herbal combination in rats with experimental myocardial infarction. Int J Integr Biol 2007 ; 1: 178-188.
21. Okhawa H., Oohishi N., Yagi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 1979 ; 95: 351-358.
22. Cabaud P., Wroblewski F. Colorimetric measurement of lactic dehydrogenase activity of body fluid. Am J Clin Pathol 1958 ; 30: 234-236.
23. Misao J., Hayakawa Y., Ohno M. et al. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 1996 ; 94: 1506-1512.
24. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 1992 ; 26: 101-108.
25. Opie LH Reperfusion injury and its pharmacologic modification. Circulation 1989 ; 80: 1049-1062.
26. Arya DS, Bansal P., Ojha SK et al. Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury. Life Sci 2006 ; 79: 38-44.
27. He HB, Yang XZ, Shi MQ et al. Comparison of cardioprotective effects of salvianolic acid B and benazepril on large myocardial infarction in rats. Pharmacol Rep 2008 ; 60: 369-381.
28. Chen X., Minatoguchi S., Wang N. et al. Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits. J Cardiovasc Pharmacol 2003 ; 41: 938-945.
29. Veeravalli KK, Akula A., Kota MK Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury. Pol J Pharmacol 2003 ; 55: 1021-1029.
30. Hartman JC The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Ann Thorac Surg 1995 ; 60: 789-792.
31. Hornig B., Kohler C., Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997 ; 95: 1115-1118.
32. Koh KK, Bui MN, Hathaway L. et al. Mechanism by which quinapril improves vascular function in coronary artery disease. Am J Cardiol 1999 ; 83: 327-331.
33. Matoba S., Tatsumi T., Keira N. et al. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Circulation 1999 ; 99: 817-822.
34. Yoshida H., Zhang JJ, Chao L. et al. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 2001 ; 35: 25-31. (Pubitemid 30054232)
35. Marktanner R., Nacke P., Feindt P. et al. Delayed preconditioning via angiotensin-converting enzyme inhibition: pros and cons from an experimental study. Clin Exp Pharmacol Physiol 2006 ; 33: 787-792.
36. Dormandy TL Free-radical oxidation and antioxidants. Lancet 1978 ; 1: 647-650.
37. Ferrari R., Agnoletti L., Comini L. et al. Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J 1998 ; 19 (suppl B). B2-11.
38. Sevanian A., Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr 1985 ; 5: 365-390.
39. Jennings RB, Murry CE, Steenbergen CJR et al. Acute myocardial ischemia: development of cell injury in sustained ischemia. Circulation 1990 ; 82: 3-12.
40. Marczin N., El-Habashi N., Hoare GS et al. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys 2003 ; 420: 222-236.
41. Bernier M., Hearse DJ, Manning AS Reperfusion-induced arrhythmias and oxygen derived free radicals. Circ Res 1986 ; 58: 331-340.
42. Bassenge E., Sommer O., Schwemmer M. et al. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 2000 ; 279: H2431-8.
43. Fliss H., Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996 ; 79: 949-956.
44. MacLellan WR, Schneider MD Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997 ; 81: 137-144.
45. Narula J., Pandey P., Arbustini E. et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 1999 ; 96: 8144-8149.
46. Cesselli D., Jakoniuk I., Barlucchi L. et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001 ; 89: 279-286.
47. Chao DT, Korsmeyer SJ Bcl-2 family: regulators of cell death. Annu Rev Immunol 1998 ; 16: 395-419.
48. Cook SA, Sugden PH, Clerk A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 1999 ; 85: 940-949.
49. Danial NN, Korsmeyer SJ Cell death: critical control points. Cell 2004 ; 116: 205-219.
50. Gustafsson AB, Gottlieb RA Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 2007 ; 292: C45-51.